erenumab-aooe

FDA Drug Profile — AIMOVIG

Drug Details

Generic Name
erenumab-aooe
Brand Names
AIMOVIG
Application Number
BLA761077
Sponsor
Amgen Inc
NDC Codes
4
Dosage Forms
INJECTION, INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
ERENUMAB

Indications and Usage

1 INDICATIONS AND USAGE AIMOVIG is indicated for the preventive treatment of migraine in adults. AIMOVIG is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults. ( 1 )